Author:
Koelink C.J.L.,van Hasselt P.,van der Ploeg A.,van den Heuvel-Eibrink M.M.,Wijburg F.A.,Bijleveld C.M.A.,van Spronsen F.J.
Subject
Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference18 articles.
1. The mutagenicity of the tyrosine metabolite, fumarylacetoacetate, is enhanced by glutathione depletion;Jorquera;Biochem. Biophys. Res. Commun.,1997
2. Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability;Jorquera;Hum. Mol. Genet.,2001
3. Tyrosinaemia type I and NTBC (2(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione);Holme;J. Inher. Metab. Dis.,1998
4. Nontransplant treatment of tyrosinemia;Holme;Clin. Liver Dis.,2000
5. The occurrence of hepatoma in the chronic form of hereditary tyrosinemia;Weinberg;J. Pediatr.,1976
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献